3.Diagnosis and treatment of end-stage liver disease.
Chinese Journal of Hepatology 2007;15(6):401-402
Humans
;
Liver Failure
;
diagnosis
;
therapy
4.The observation on the effect of sufentanil combined with ropivacaine in interscalene brachial plexus block by ultrasound-mediated
Chinese Journal of Primary Medicine and Pharmacy 2013;20(4):502-504
Objective To explore clinical effect of sufentanil combined with ropivacaine in interscalene brachial plexus block by ultrasound-mediated.Methods 66 patients received the treatment of interscalene brachial plexus block were divided into group A,B and C randomly.Group A received traditional blind puncture interscalene brachial plexus block with ropivacaine;Group B received interscalene brachial plexus block with ropivacaine by ultrasound-mediated;Group C received interscalene brachial plexus block with combination of sufentanil and ropivacaine by ultrasound-mediated.The operation time,VAS score,pain and movement block onset time,anesthesia fine ratio and incidence of complications were observed and compared.Results The operation times of group B and C were significantly shortened compared with group A(all P <0.05) ;The pain and movement block onset time was shortened significantly in group B (all P < 0.05),and more significantly in group C than those in group A (all P < 0.05) ;The VAS score at 30min,60min and 120min after operation of brachial plexus block were significantly decreased in group C than those in group A and B (all P < 0.05) ; Anesthesia fine ratio in group B and C significantly improved than that in group A (all P < 0.05) ; Incidence of complications of group B and C was significantly lower than that in group A after operation of brachial plexus block (all P < 0.05).Conclusion Sufentanil combined with ropivacaine in interscalene brachial plexus block by ultrasound-mediated has good effect and safety,and it can improve the onset time and effect of pain and movement block.
6.Clinical study on Yihong Kangnaoshuan capsule in treating lacunar infarction pure motor hemiparesis.
China Journal of Chinese Materia Medica 2015;40(11):2235-2238
With the treatment of lacunar cerebral infarction with pure motor hemiparesis (PMH) attach importance to the treatment effect, application benefit of Yihong Kangnaoshuan capsule in the treatment of further effect. Treatment of PMH is mainly depending on the thorough discussion on the cause, to determine the clinical value of treatment based on the principle of. Through the research of Zhejiang People's Hospital of Fenghua from 2013 March to 2014 September 178 cases of pure motor hemiparesis were the benefit of Yihong Kangnaoshuan capsule and vedrin capsule treatment, compared the indexes of efficacy after treatment and blood rheology. Finally found the benefits of Yihong Kangnaoshuan capsule in the application process with high safety, efficacy and greater proportion. And in favor of blood lipid and blood rheology indicators of stability, the repair of neurological function is more. Therefore, clinicians should be applied benefit of red brain thrombus capsule in the treatment of PMH. But the overall difference between drugs is need to further comparison, in order to ensure clinical curative effect.
Adult
;
Aged
;
Capsules
;
Cerebral Infarction
;
drug therapy
;
Drugs, Chinese Herbal
;
therapeutic use
;
Female
;
Humans
;
Male
;
Middle Aged
;
Paresis
;
drug therapy
7.Screening and identification of the genes trans-regulated by hepatitis B virus pre-S1 protein with microarray assay
Dong JI ; Jun CHENG ; Jing DONG
Medical Journal of Chinese People's Liberation Army 2001;0(10):-
Objective To evaluate the influence of expression of pre S1 protein on the genomic expression of hepatitis B virus (HBV) infected hepatocyte with microarray. Methods The differentially expressed genes between the hepatoblastoma cell line HepG2 transfected by pcDNA3.1(-) and pcDNA3.1(-)-preS1, were respectively compared by cDNA microarray technique. The HBV pre-S1 coding DNA fragment was amplified with polymerase chain reaction (PCR) technique by using G376-7 plasmid DNA containing the full length of HBV genome as the template. The expressive vector of pcDNA3.1-preS1 was constructed by routine molecular biological methods. HepG2 cells were transfected by pcDNA3.1(-) and pcDNA3.1-preS1, respectively, using FuGENE6 Transfection Reagent. The total RNA was isolated and reversely transcribed. Results The cDNAs were subjected for microarray screening with 1152 cDNA probes. From the scanning results, it was found that 30 genes were up-regulated and 38 genes were down-regulated by pre-S1 protein of HBV. Conclusion The expression of pre-S1 protein affected the genomic expression spectrum of HBV infected hepatocyte(HepG2 cell line).
8.A winning war against hepatitis B virus infection in China.
Chinese Medical Journal 2007;120(24):2157-2158
9.Progress in diagnosis and treatment of liver cirrhosis.
Chinese Journal of Hepatology 2009;17(4):241-243